Hey SF, If Zen 3694 were to be sold I don't think the idea of ZCC investing in RVX Is thinking which is too out of the box. I agreed with that in a post in April. I don't think they would have to invest nearly $100 MM though. To me all that will be needed is money to complete BetOnMace and move some of the other programs into gear, which seat of the pants would seem to be $20 to $40MM.

As long as the science remains strong I think Eastern will want to continue guaranteeing the loan. When I do the math I think Eastern has better down side protection for their entire investment with the guarantee and corresponding collateral in place rather than no longer guaranteeing the loan and having no collateral protection thus letting their roughly $30MM cash investment ride naked (with no downside protection).  In any event just one potential scenario of many although unless a take out occurs I do think we will see Eastern continue as at least a loan guarantor, protecting their downside and enhancing their upside.

As far as fixing a deal price between related parties I think that would be quite easy to do fairly given that Hepalink has no interest in Zenith so would want to see a deal which leaned toward favouring RVX while Eastern would likely want to see a deal leaning Zenith's way given their 38% stake in Zenith